ZA9210120B - N-(3-(2-(1 H-imidazol-1-yl)ethoxy)-4-(2-thienyl)-2-pyrimidinamine and pharmacologically acceptable salts - Google Patents

N-(3-(2-(1 H-imidazol-1-yl)ethoxy)-4-(2-thienyl)-2-pyrimidinamine and pharmacologically acceptable salts

Info

Publication number
ZA9210120B
ZA9210120B ZA9210120A ZA9210120A ZA9210120B ZA 9210120 B ZA9210120 B ZA 9210120B ZA 9210120 A ZA9210120 A ZA 9210120A ZA 9210120 A ZA9210120 A ZA 9210120A ZA 9210120 B ZA9210120 B ZA 9210120B
Authority
ZA
South Africa
Prior art keywords
pyrimidinamine
imidazol
thienyl
ethoxy
acceptable salts
Prior art date
Application number
ZA9210120A
Other languages
English (en)
Inventor
Rolf Paul
Robert Gerard Kelly
Lawrence W Torley
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of ZA9210120B publication Critical patent/ZA9210120B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA9210120A 1991-12-31 1992-12-30 N-(3-(2-(1 H-imidazol-1-yl)ethoxy)-4-(2-thienyl)-2-pyrimidinamine and pharmacologically acceptable salts ZA9210120B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/816,335 US5162328A (en) 1991-12-31 1991-12-31 N-[3-[2-(1H-imidazol-1-yl)ethoxy]phenyl]-4-(2-thienyl)-2-pyrimidinamine and pharmacologically acceptable salts

Publications (1)

Publication Number Publication Date
ZA9210120B true ZA9210120B (en) 1994-04-12

Family

ID=25220310

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9210120A ZA9210120B (en) 1991-12-31 1992-12-30 N-(3-(2-(1 H-imidazol-1-yl)ethoxy)-4-(2-thienyl)-2-pyrimidinamine and pharmacologically acceptable salts

Country Status (16)

Country Link
US (1) US5162328A (xx)
EP (1) EP0549880B1 (xx)
JP (1) JPH05271227A (xx)
KR (1) KR930012761A (xx)
AT (1) ATE171178T1 (xx)
AU (1) AU651539B2 (xx)
CA (1) CA2086357A1 (xx)
DE (1) DE69227015T2 (xx)
DK (1) DK0549880T3 (xx)
ES (1) ES2121809T3 (xx)
FI (1) FI925951A (xx)
HU (1) HUT66943A (xx)
NO (1) NO301476B1 (xx)
NZ (1) NZ245513A (xx)
SG (1) SG47556A1 (xx)
ZA (1) ZA9210120B (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7803806B2 (en) * 2005-11-03 2010-09-28 Sgx Pharmaceuticals, Inc. Pyrimidinyl-thiophene kinase modulators

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4788195A (en) * 1986-01-13 1988-11-29 American Cyanamid Company 4,5,6-substituted-N-(substituted-phenyl)-2-pyrimidinamines
SG47583A1 (en) * 1986-01-13 1998-04-17 American Cyanamid Co 4,5,6-Substituted-n- (substituted-phenyl) -2- pyrimidinamines

Also Published As

Publication number Publication date
DE69227015T2 (de) 1999-03-25
AU3046292A (en) 1993-07-08
ES2121809T3 (es) 1998-12-16
NO301476B1 (no) 1997-11-03
HU9204172D0 (en) 1993-04-28
NO924760D0 (no) 1992-12-09
NZ245513A (en) 1994-07-26
FI925951A0 (fi) 1992-12-30
SG47556A1 (en) 1998-04-17
HUT66943A (en) 1995-01-30
JPH05271227A (ja) 1993-10-19
KR930012761A (ko) 1993-07-21
EP0549880A1 (en) 1993-07-07
CA2086357A1 (en) 1993-07-01
ATE171178T1 (de) 1998-10-15
US5162328A (en) 1992-11-10
DE69227015D1 (de) 1998-10-22
EP0549880B1 (en) 1998-09-16
AU651539B2 (en) 1994-07-21
DK0549880T3 (da) 1999-06-14
FI925951A (fi) 1993-07-01
NO924760L (no) 1993-07-01

Similar Documents

Publication Publication Date Title
NO933093D0 (no) Monohydrat av 5-(2-(4-(1,2-benzisotiazol-3-yl)-1-piperazinyl)-etyl)-6-klor-1,3-dihydro-2h-indol-2-on hydroklorid
DK0957099T3 (da) Heterocykliske carboxamider
NZ237565A (en) Substituted thiazolidinones, oxazolidinones or imidazolidinones and antiinflammatory pharmaceutical compositions thereof
RU93043528A (ru) Моногидрат 5-(2-(4-(1,2-бензотиазол-3-ил)-1-пиперазинил)этил)-6-хлор-1,3-дигидро-2н-индол-2-он хлоргидрата, способ его получения, фармацевтическая композиция, способ лечения
NO964950L (no) Krystallinsk hydroklorid av (R)-(-)-2-{N-£4-(1,1-dioksido-3-okso-2,3-dihydro-benziso-tiazol-2-yl)-butyl|-aminometyl}-kroman
DE69526862D1 (de) Azol-derivate
GR3032220T3 (en) Use of 2-(N-(2-aminoethyl)amino)acetic acid derivatives for the treatment of diseases which are mediated by non-enzymatical glycosylation
DE69323667T2 (de) 4-substituierte 1,2,4-Triazolderivate
HK21595A (en) Use of 1-(3-dimethyl-amino)propyl)-1-phenylphthalenes for the treatment of cerebrovascular disorders
DE69428665T2 (de) Hemmung von CNS-Problemen bei Frauen nach der Menopause
MX9606305A (es) Productos de proteccion de cultivos.
PT790236E (pt) Pro-farmacos de 5-(2-(4-(1,2-benzisotiazol-3-il)-1-piperazinil)-etil-6-cloro-1,3-di-hidro-2h-indol-2-ona
ZA9210120B (en) N-(3-(2-(1 H-imidazol-1-yl)ethoxy)-4-(2-thienyl)-2-pyrimidinamine and pharmacologically acceptable salts
MX9205186A (es) Derivados de 4-[4-[4-(4-hidroxifenil)-1-piperazinil]-fenil]-5-metil-3h-1,2,4-triazo l-3-ona
NZ336585A (en) 2,6-dimethyl-4-(3-nitro-phenyl)-5-methoxycarbonyl-1,4-dihydropyridine-3-carboxylate derivatives substituted by N-[5-(1H-2-pyrrolyl)-5-oxopentyl] or [4-(2-thienoyl or 2,4,6-trimethoxybenzoyl)-butyl]-pyrrolid-3-ine or piperid-3-ine
TW362097B (en) 3-Phenyl-1, 4-dialkyl-1,2,4-triazolium salts and their use as antidepressants